Replies to post #20007 on Biotech Values

[kaivamei]

GTCB - 5 year warrants

I thought there would be further financing and voted accordingly on Dew's survey. I don't think it necessarily indicates a lack of company confidence or that further delays from EMEA are coming. No matter how good the odds are, the company has to be prudent and plan for the contingency of further delays, since they are at least possible.

I like the terms of the deal - no discount, registered - as Dew pointed out. The one thing that bothers me is the 5 year term of the warrants. Isn't that rather a long window? To my mind, even three years is long. Is there anything in this deal to prevent the warrants from being used to facilitate/protect shorting?

-kaivamei

[io_io]

Re: GTCB financing (good news, bad news)

I have often seen speculation that big money must treat big money well. You have to respect the $multi-m cash infusions.

My theory is that in September the investors of August got blind-sided by the EMEA delay. I can't believe they would be investing again without a very strong assurance.